It’s a barely a five-minute walk from New Delhi’s Patel Nagar metro station. The lane, bristling with commercial activity, stands out by itself. Sweet shops, bakeries, juice shops, spy camera vendors, or even a small outlet selling Ayurvedic medicines for in-vitro fertility treatment. South Patel Nagar has it all. Amidst all this chaos, in a building with a juice outlet to the front and up a narrow flight of stairs, is Aimil Pharmaceuticals, a little-known company which is kicking up some chaos in the medical world too.
A dubious diabetes drug, regulatory confusion, and a potential PIL
A drug which conveniently swings between Ayurvedic supplement and modern medicine, is baffling doctors, patients, scientists, and even the US FDA. The Prime Minister has hailed it as the ‘first’ Ayurvedic medicine for diabetes but, alas, he hasn’t looked at the evidence
